Follow-up of patients diagnosed with germinal testicular tumors (seminomas and non-seminomatous) treated with bone marrow transplant and high dose of chemotherapy

Introducción: Germinal testicular tumors are the most common malignant neoplasm in men around 20 to 34 years. Even though they unusual, have increased incidence last decade; an excellent prognosis and overall survival at five years, approximately 95%. Divergent data exists regarding treatment options patients with first, second, third relapses conventional therapy. Some studies describe possible benefit of using high-dose chemotherapy associated a bone marrow transplant variable results